Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 12.26
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Gennex Laboratories Ltd. engages in the manufacture of bulk drugs, intermediates and biotech products. It operates through the following geographical segments: Germany, Egypt, Iran, Peru, Spain, Guatemala City, South Korea, Vietnam, Export Others, and India. The company was founded on March 29, 1990 and is headquartered in Hyderabad, India.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is 'cheap' on P/E, neutral on EV/EBITD.
Data is available to registered users only
Buy
Sell